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Abstract The homotetrameric aquaporin-2 (AQP2) water
channel is essential for the concentration of urine and of critical
importance in diseases with water dysregulation, such as
nephrogenic diabetes insipidus, congestive heart failure, liver
cirrhosis and pre-eclampsia. The structure of human AQP2 is a
prerequisite for understanding its function and for designing
specific blockers. To obtain sufficient amounts of AQP2 for
structural analyses, we have expressed recombinant his-tagged
human AQP2 (HT-AQP2) in the baculovirus/insect cell system.
Using the protocols outlined in this study, 0.5 mg of pure
HT-AQP2 could be obtained per liter of bioreactor culture.
HT-AQP2 had retained its homotetrameric structure and
exhibited a single channel water permeability of 0.93 þ 0.03U
10313 cm3/s, similar to that of other AQPs. Thus, the baculo-
virus/insect cell system allows large-scale expression of func-
tional recombinant human AQP2 that is suitable for structural
studies. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Water is the major constituent of all living cells and their
environment. Therefore, water transport across cell mem-
branes is crucial for all forms of life. Although water may
cross lipid bilayers by simple di¡usion, many physiological
processes involving £uid transport require specialized water
channels, called aquaporins (AQPs). These proteins belong
to the family of the major intrinsic protein of the eye lens
(MIP), which comprises some 200 members found in man,
animals, plants and microorganisms [1]. In mammals, 10
AQPs have thus far been identi¢ed [2]. They are expressed
in di¡erent tissues and are thought be involved in several
processes of £uid transport, including osmoregulation and
water conservation by the kidney, £uid secretion and absorp-
tion by epithelia of the gastrointestinal, respiratory and repro-
ductive tracts and their associated exocrine glands, and the
formation of cerebrospinal £uid, aqueous humor, amniotic
£uid and sweat [2,3]. In the kidney, AQPs 1^4 and 6^8 are
expressed, but at present the speci¢c role in renal water con-
servation has only been established for AQPs 1^4 [4,5]. Of the
180 l of pro-urine produced daily, 90% is reabsorbed via
AQP1, which is expressed in the basolateral and apical mem-
branes of epithelial cells in the proximal tubules and descend-
ing limbs of Henle. Water reabsorption in the collecting duct
is mediated through AQP2 in the apical membrane, and
through AQP3 and AQP4 in the basolateral membrane, and
is under the control of the anti-diuretic hormone vasopressin
(AVP) [6^8]. After binding of AVP to its V2-receptor at the
basolateral side of renal principal collecting duct cells, activa-
tion of cAMP-dependent protein kinase A (PKA) results in
the redistribution of the homotetrameric AQP2 protein from
intracellular storage vesicles to the apical plasma membrane,
where it can exert its function as a water channel. Removal of
AVP reverses this process, restoring the water-impermeable
cell layer. AQP2 plays a critical role in regulating the body
water balance: First, AQP2 is involved in congenital and ac-
quired Nephrogenic Diabetes Insipidus, where the kidney is
unable to concentrate urine in response to AVP [5,9^11]. Sec-
ond, in diseases such as congestive heart failure [11^14], liver
cirrhosis [14^17] and pre-eclampsia [11,14,18,19], the unre-
stricted water reabsorption via AQP2 may lead to life-threat-
ening hyponatremia. Because AQP2 is directly involved in
these disturbances of the body osmoregulation, rational de-
sign of speci¢c AQP2 blockers is of prime clinical relevance.
For this, elucidation of its 3D structure is an obligatory pre-
requisite.
Thus far the atomic structures of AQP1 and GlpF have
been described, while 2D crystals of several AQPs have been
produced. In addition, 3D crystals of AQP1 yielding di¡rac-
tion to 2.2 Aî have recently been reported [20]. Crystallization
of all three of these proteins has been greatly aided by the
availability of large amounts of highly pure protein. The bac-
terial channel proteins AqpZ and GlpF have been expressed
as recombinant proteins in Escherichia coli and isolated using
a poly-histidine tag [21,22]. MIP26 has been isolated from
lenses, where it makes up 50^60% of the membrane proteins
[23] and AQP1 has been puri¢ed from human and bovine
erythrocytes in which it is expressed in high levels [24]. In
contrast, AQP2 is only noticeably present in renal principal
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collecting duct cells [25] and testis [26], which renders large-
scale isolation of AQP2 from natural sources impossible.
In the present study we expressed recombinant his-tagged
human AQP2 in Sf9 insect cells, optimized the expression and
puri¢cation of this recombinant protein, and functionally
characterized it after reconstitution into lipid bilayers. Su⁄-
cient amounts of functional human AQP2 have been obtained
and with this the basis has been laid for further studies on 2D
crystallization and structural analysis of this protein.
2. Materials and methods
2.1. cDNA cloning and production of baculovirus
For the expression of AQP2 in Sf9 insect cells, the Bac-to-Bac
baculovirus expression system (Gibco BRL) was used. Human
AQP2 cDNA was ampli¢ed from an AQP2-containing pBluescript
vector [10] using the primer AQP2-for-1 (ATGTGGGAGCTC-
CGCTCCATAGC), corresponding to positions 1 to 23 of the human
AQP2 coding sequence, and an extended T3 RNA polymerase reverse
primer. The obtained PCR product of 860 bp was digested with
HindIII and ligated into the pFastBac-HT-b vector, which was pre-
viously digested with SfoI and HindIII. The resulting construct, pFB-
HT-AQP2, encodes AQP2 with a poly-histidine tag and an rTEV
protease cleavage site [27] £anking the N-terminus of AQP2 (Fig.
1). This construct was sequenced and subsequently transformed into
competent DH10Bac E. coli cells, to allow transposon-directed recom-
bination with the baculovirus genome. High molecular weight re-
combinant bacmid DNA was isolated from positive clones and trans-
fected into Sf9 insect cells using the cellfectin reagent (Gibco BRL).
Baculovirus stocks were obtained from the supernatant of these cul-
tures after approximately 3 days, and titrated.
2.2. Expression of HT-AQP2
This procedure was adapted from the one optimized for recombi-
nant his-tagged rhodopsin [28]. Sf9 cells were grown in a 15-l bioreac-
tor (Applikon) containing 10 l of Insect Xpress medium (BioWhit-
taker), which was gently stirred at 80 rpm and kept at a constant 50%
oxygen-saturation level and 27‡C. Cells were grown to a density of
V1.5U106 cells/ml, at which point the culture was infected with
HT-AQP2 encoding baculovirus at an MOI of 0.05. A small sample
was taken daily to follow expression of HT-AQP2. At day 5 or 6,
when oxygen use of the culture had declined to zero, HT-AQP2 ex-
pression was at a maximum. At this point, cells were harvested by
10 min centrifugation at 5000Ug and 4‡C.
2.3. Immunocytochemistry of Sf9 cells
Sf9 insect cells were grown on coverslips and infected with HT-
AQP2 encoding baculovirus. Two days after infection, cells were ¢xed
and permeabilized as described [29], and incubated with a⁄nity-puri-
¢ed rabbit antibodies directed against the last 15 amino acids of rat
AQP2 [30]. AQP2 was visualized using FITC-coupled goat K-rabbit
IgG (Sigma) as secondary antibodies. Mock-infected Sf9 cells were
used as a control. Images were taken with a Bio-Rad MRX-1000
confocal laser scanning microscope.
2.4. Immunoblotting
Protein samples were subjected to electrophoresis on a 13% SDS^
polyacrylamide gel and immunoblotted onto PVDF membranes
(Millipore) by standard procedures. Membranes were blocked for 1 h
in 5% non-fat-dried milk in TBS-T (TBS with 0.1% Tween 20) and
incubated overnight at 4‡C with a⁄nity-puri¢ed rabbit anti-AQP2
antibodies [30], diluted 1:3000 in TBS-T containing 1% non-fat-dried
milk. Subsequently, blots were incubated for 1 h at RT with 1:5000-
diluted goat K-rabbit IgG coupled to horseradish peroxidase. AQP2
was visualized using enhanced chemoluminescence (Pierce).
2.5. Urea/alkaline stripping of membranes
Urea/alkaline stripping was performed essentially as described [31].
Brie£y, insect cells were centrifuged for 10 min at 3000Ug and ho-
mogenized in cold 5 mM Tris^HCl, 100 mM NaCl, pH 8.0 at 1U108
cells/ml by 20 strokes at 500 rpm in a Potter^Elvehjem tube. Mem-
branes were pelleted by 30 min centrifugation at 100 000Ug and 4‡C.
The membrane pellet was homogenized in 5 mM Tris, 1 mM EDTA,
4 M Urea, pH 8.0 as above and centrifuged for 45 min at 100 000Ug
and 4‡C. The resulting pellet was homogenized in 20 mM NaOH (pH
12) and centrifuged for 90 min at 100 000Ug and 4‡C. The ¢nal pellet
was subjected to two rounds of homogenization in 5 mM Tris, 100
mM NaCl, pH 8.0 and 30 min centrifugation at 100 000Ug and 4‡C,
to neutralize the pH.
2.6. Determination of the oligomerization state of HT-AQP2
Urea/alkali-stripped membranes of HT-AQP2-expressing insect
cells from 100 ml of culture were solubilized in 50 ml solubilization
bu¡er (20 mM Tris, 300 mM NaCl, 1 mM L-histidine, 10% glycerol,
0.01% NaN3, pH 8.0) containing 4% OG by 10 strokes at 500 rpm in
a Potter^Elvehjem tube and overnight stirring at 4‡C. After 60 min
centrifugation at 100 000Ug and 4‡C, a 200-Wl sample of solubilized
protein was loaded onto a 4.0-ml 5^17.5% sucrose gradient in 20 mM
Tris (pH 8.0), 5 mM EDTA, 0.1% Triton X-100 and centrifuged for
16 h at 150 000Ug. The position of the HT-AQP2 peak was deter-
mined by immunoblot analysis of 250-Wl fractions taken from the
gradient. Marker proteins were used to estimate the oligomeric size
of HT-AQP2. Membranes of Xenopus oocytes expressing wild-type
AQP2 [32] were solubilized in the same manner and taken as a con-
trol.
2.7. Puri¢cation of HT-AQP2
The membrane pellet of a 10-l expression culture of HT-AQP2 was
urea/alkaline stripped and homogenized in solubilization bu¡er con-
taining 4% OG (25 ml/l culture) by 20 strokes at 500 rpm in Potter^
Elvehjem tubes. Membranes were solubilized by gentle overnight stir-
ring at 4‡C. Solubilized proteins were separated from insoluble frac-
tions by 60 min centrifugation at 100 000Ug and 4‡C, and diluted by
adding an equal volume of solubilization bu¡er. HT-AQP2 was
bound to Ni^NTA by adding 400 Wl of a 50% ‘slurry’ of Ni^NTA
beads to 50 ml of solubilized proteins and gentle overnight stirring at
4‡C. The beads with bound HT-AQP2 protein were centrifuged for
15 min at 4000Ug and 4‡C, and washed once with solubilization
bu¡er containing 2% OG. Pure HT-AQP2 was eluted by incubation
with solubilization bu¡er containing 2% OG and 100 mM L-histidine
(1 ml/l of original culture) during 2 h of gentle stirring at 4‡C. After
centrifugation, the HT-AQP2-containing supernatant was directly
used for further analysis.
2.8. Functional analysis of puri¢ed HT-AQP2
Puri¢ed HT-AQP2 was reconstituted into proteoliposomes by mix-
ing with E. coli lipids and overnight dialysis against liposome bu¡er
(20 mM Tris^HCl, 50 mM NaCl, pH 7.2) at room temperature. Pro-
teoliposomes were ¢ltered through a 0.2-Wm ¢lter and diluted to
0.2 mg lipid/ml. The average vesicle diameter was calculated from
electron micrographs of negatively stained vesicles [33]. For functional
analysis, vesicles were subjected to an inwardly directed sucrose gra-
dient of 100 mOsm/kg H2O through rapid mixing in an Applied
PhotoPhysics SX18.MV stopped-£ow apparatus. The decrease of
vesicle volume was measured from the increase in 90‡ scattered light
at V= 450 nm. Data from 10 measurements were averaged and light
scattering was normalized at t = 10 s. The ability of mercuric com-
pounds to inhibit HT-AQP2 water transport was investigated by the
addition of 1 mM HgCl2 15 min prior to measurements. Time courses
were ¢tted to single-exponential curves, allowing determination of
the rate constant of HT-AQP2-facilitated water transport, k, by sub-
tracting the rate constants of HgCl2-treated vesicles from those of
untreated vesicles. The osmotic water permeability coe⁄cient (Pf in
cm/s) was calculated according to the equation Pf = k/((S/V0)WVwW
(Cout3Cin)Wc), where (S/V0) is the mean vesicle surface area to initial
volume ratio, Vw is the partial molar volume of water, (Cout3Cin) is
the di¡erence in external and internal osmolarity, and c is the re£ec-
tion index of glucose (cglu = 1) [34]. The single channel water perme-
ability (pf ) was calculated using the formula pf = Pf /SuD, where SuD
is the single channel density per unit of surface area. SuD was calcu-
lated from the lipid to protein ratios (LPR) of the proteoliposomes
(protein determination via amido-black 10B assay [35] and phospho-
lipid determination via an ammonium ferrothiocyanate assay [36]) and
an E. coli lipid surface density of 2.7 kDa/nm2 [33]. Liposomes with-
out protein were used as controls.
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3. Results
Using the Bac-to-Bac baculovirus expression system, a ba-
culovirus was constructed that allows expression of AQP2
with a poly-histidine tag and an rTEV protease cleavage site
£anking its N-terminus. Thus the HT-AQP2 can e⁄ciently be
puri¢ed from insect cell membranes by Ni-a⁄nity chromatog-
raphy. In addition, by treatment with rTEV protease, the
recombinant HT-AQP2 can be reverted to a protein that
only has an additional glycine at its N-terminus compared
to the wild-type AQP2 protein (Fig. 1).
In collecting duct principal cells AVP promotes redistribu-
tion of AQP2 from intracellular vesicles to the plasma mem-
brane. To locate the recombinantly expressed HT-AQP2 pro-
tein in insect cells, Sf9 cells infected with HT-AQP2
baculovirus at an MOI of 1 were subjected to immuno£uo-
rescent labeling 2 days after infection, and analyzed by con-
focal laser scanning microscopy. At this time point, where
some but not yet all cells expressed HT-AQP2, speci¢c stain-
ing for AQP2 was found in and close to the plasma membrane
(Fig. 2). Mock-infected cells did not show any staining (not
shown). This distribution was con¢rmed by cell fractionation
experiments, which demonstrated HT-AQP2 to be present in
similar amounts in both the plasma membrane and the vesicle
fraction (not shown). Therefore, the total membrane fractions
of insect cells were subsequently used for the puri¢cation of
HT-AQP2.
To purify HT-AQP2 suitable for structural analyses it has
to be solubilized from insect cell membranes by a detergent
that (1) allows e⁄cient binding of HT-AQP2 to Ni^NTA
beads, (2) does not impair the structure of HT-AQP2, (3)
conserves the functionality of HT-AQP2 as a water channel
and (4) enables the reconstitution of HT-AQP2 into 2D crys-
tals via dialysis or its assembly into 3D crystals. Of the deter-
gents tested, 4% n-octyl-L-D-glucopyranoside (OG) appeared
to be most e¡ective during solubilization and Ni binding of
HT-AQP2, although this detergent did require prior urea/al-
kaline stripping of the insect cell membranes for e⁄cient sol-
ubilization.
As shown for other AQPs [21,37^40], in vivo and when
heterologously expressed in Xenopus oocytes, AQP2 is a
homotetramer [32]. To test whether HT-AQP2 expressed in
insect cells is a homotetramer as well that survives solubiliza-
tion with OG, HT-AQP2 was solubilized from stripped insect
cell membranes with 4% OG and analyzed by sucrose gradient
centrifugation. Wild-type AQP2 expressed in Xenopus oocytes
served as a control. As can be seen in Fig. 3A, immunoblot-
ting of fractions from the sucrose gradient revealed that HT-
AQP2 peaked in the fraction running at 150 kDa [L], while
wt-AQP2 was most abundant in the fraction running at a
slightly lower molecular mass [K]. Since the molecular mass
of HT-AQP2 is 32 kDa and that of wild-type AQP2 is 29
kDa, the sedimentation measurements are compatible with
tetrameric structures for both proteins. The tetrameric orga-
nization of HT-AQP2 was further con¢rmed by negative
staining electron microscopy of solubilized HT-AQP2 protein
(Fig. 3B), followed by single particle analysis using the Sem-
per program [41]. The resulting average image of 162 HT-
AQP2 particles (Fig. 3C) clearly shows a tetrameric structure
for this protein. Therefore, HT-AQP2 expressed in Sf9 insect
cells appears to be correctly and stably folded, allowing its
tetrameric structure to endure solubilization with 4% OG.
For future crystallization experiments, HT-AQP2 has to be
puri¢ed from large bioreactor expression cultures to obtain
su⁄cient amounts of protein. At an MOI of 0.05, used in
such cultures [28], the expression of HT-AQP2 started around
day 3 and reached a maximum 5 to 6 days after infection.
Interestingly, this coincided with the rise and fall of oxygen
use of the cell culture (not shown). Depending on the individ-
ual expression pro¢le, cells were therefore harvested at day 5
or 6. HT-AQP2 was puri¢ed according to the procedure de-
Fig. 1. Sequences of the N-termini of AQP2 proteins. The N-termini
of wild-type AQP2, recombinant his-tagged AQP2 (HT-AQP2) and
HT-AQP2 after treatment with rTEV protease are shown. The rec-
ognition sequence of rTEV protease is underlined.
Fig. 2. Localization of HT-AQP2 in infected Sf9 insect cells. Confo-
cal laser scanning microscopy revealed plasma membrane and intra-
cellular vesicular staining after immunocytochemical analysis for
AQP2. Relative size and position of an insect cell nucleus is indi-
cated in one cell (N).
Fig. 3. Determination of the oligomeric size of HT-AQP2. Insect
cell membranes containing HT-AQP2 were solubilized in 4% OG
and subjected to sucrose gradient centrifugation (A). Fractions from
this sucrose gradient (A to R) were subjected to immunoblotting for
AQP2. Peak fractions of marker proteins are indicated by arrows
and their molecular masses in kDa. Recombinant wild-type AQP2
was used as a control. Negatively stained solubilized HT-AQP2 par-
ticles were also analyzed by means of electron microscopy (B) and
averaged (C) to show the tetrameric structure of the protein after
solubilization in OG.
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scribed above. The level of puri¢cation in each step was an-
alyzed by PAGE-separation followed by Coomassie-staining
(Fig. 4A) or immunoblotting (Fig. 4B). Urea/alkaline strip-
ping (Fig. 4A, lanes 3 through 6) was found to e⁄ciently
remove contaminating proteins, while only a very small
amount of HT-AQP2 protein (running at V30 kDa) was
lost (Fig. 4B, same lanes). With 4% OG, about 50% of the
HT-AQP2 protein could be solubilized from the stripped
membranes (Fig. 4B, lanes 7 and 8). Ni-a⁄nity binding and
subsequent elution of HT-AQP2 proved to be very e⁄cient,
since hardly any HT-AQP2 was found in the Ni^NTA £ow-
through (Fig. 4B, lane 9) while nearly all HT-AQP2 eluted
from the Ni^NTA beads at 10- and 100-mM concentrations
of L-histidine (Fig. 4B, lanes 10 through 13). The eluted HT-
AQP2 appeared to be very pure (Fig. 4A, lanes 10 through
13). Approximately 0.5 mg of pure HT-AQP2 protein (out of
a total of 1.6 mg HT-AQP2 initially expressed) could be ob-
tained for each liter of insect cell culture, corresponding to a
yield of V37%.
The functionality of our puri¢ed HT-AQP2 was assessed
with proteoliposomes whose osmotically driven shrinkage
was measured by stopped-£ow light scattering. Vesicle shrink-
age of proteoliposomes containing HT-AQP2 appeared to oc-
cur much faster than with control liposomes containing no
protein (Fig. 5A). Upon treatment of proteoliposomes with
1 mM HgCl2, however, the HT-AQP2-facilitated water trans-
port was completely reduced to control levels (Fig. 5B), fur-
ther indicating that the increased osmotic shrinkage of HT-
AQP2-containing vesicles was completely AQP-mediated.
From the rate constants of the ¢tted curves and the average
diameter of the proteoliposomes (Table 1), the single channel
water permeability coe⁄cient (pf ) of HT-AQP2 was deter-
mined to be 0.91 þ 0.04U10313 cm3/s at an LPR of 60, and
0.95 þ 0.04U10313 cm3/s at an LPR of 90. From these mea-
surements, the resulting average pf of HT-AQP2 equals
0.93 þ 0.03U10313 cm3/s.
4. Discussion
To lay the foundation for crystallization and structural
analysis of AQP2, which is required for understanding the
function of this water channel and for rational design of spe-
ci¢c AQP2 blockers, high amounts of pure AQP2 needed to
be produced. Since the amount expressed in renal collecting
ducts is by far not su⁄cient, AQP2 needs to be heterologously
expressed. As also shown by others [42] and as can be ex-
pected for eukaryotic integral membrane proteins, AQP2
could not be expressed in E. coli. As demonstrated in this
Table 1
Overview of measured and calculated vesicle properties
LPR 60 LPR 90
dv 0.74 þ 0.02U1035 cm 0.60 þ 0.01U1035 cm
dem 1.04 þ 0.03U1035 cm 0.85 þ 0.02U1035 cm
k 18.8 þ 0.8 s31 13.1 þ 0.6 s31
SuD 1.4113U1011 cm32 7.6075U1010 cm32
Pf 1.29 þ 0.06U1032 cm/s 0.72 þ 0.03U1032 cm/s
pf 0.91 þ 0.04U10313 cm3/s 0.95 þ 0.04U10313 cm3/s
Average spherical vesicle diameters (dv) were calculated from the
average diameters obtained from electron micrographs (dem) of neg-
atively stained proteoliposomes (LPR 60, n = 87; LPR 90, n = 51).
Rate constants of HT-AQP2 facilitated water transport (k) were cal-
culated by subtracting the rates of HgCl2-treated vesicles from those
of the corresponding untreated vesicles. SuD, Pf and pf were calcu-
lated as described in Section 2.
Fig. 4. Puri¢cation of HT-AQP2 from large bioreactor culture. In-
sect cell membranes containing HT-AQP2 were urea/alkaline
stripped and solubilized in OG. HT-AQP2 was then puri¢ed via Ni-
a⁄nity chromatography. Samples were taken from all steps during
this procedure to establish the purity of the product after each step
by Coomassie-staining of samples loaded on a gel (A) and to esti-
mate the yield of each step by immunoblotting the samples for
AQP2 (B). The last four lanes of the Coomassie-stained gel, show-
ing elution of HT-AQP2 from Ni^NTA beads, are 100U more con-
centrated than the previous lanes in order to visualize the HT-
AQP2 protein. Higher bands in immunoblot most likely represent
cross-linked products.
Fig. 5. Stopped-£ow analysis of HT-AQP2 reconstituted in proteoli-
posomes. Proteoliposomes containing HT-AQP2 were subjected to
an inwardly directed osmotic gradient by rapid mixing in a stopped-
£ow spectrometer, and vesicle shrinkage was followed by measuring
the increase in scattered light. Graphs show the average time course
(n = 10) of HT-AQP2-containing proteoliposomes at an LPR of
60 compared to empty control liposomes. All data were ¢tted to
single-exponential curves. Water transport was measured without
(A) or with the addition of 1 mM HgCl2 (B), an inhibitor of AQP
function.
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study, however, expression in the baculovirus/insect cell ex-
pression system resulted in large amounts of HT-AQP2 (i.e.
1.6 mg/l of culture). This level of expression was slightly lower
than reported for AQP4 in the same system (2.1 mg/l of cul-
ture; [43]).
While prior urea/alkaline stripping of the membranes was
essential for e⁄cient solubilization, the coupled poly-histidine
tag proved to be convenient for the isolation of HT-AQP2
from insect cell membranes (Fig. 4). It allowed a 37% recovery
(i.e. 0.5 out of 1.6 mg) of highly pure HT-AQP2. In contrast,
only 5% (0.11 mg/l of culture) of non-tagged AQP4 could be
isolated from insect cells [43]. A his-tagged version of AQP4
in the same study had a better yield, however, in contrast to
the recombinant wild-type AQP4 it appeared to have no water
transport activity [43]. Therefore, analysis of the oligomeric
structure and function of an isolated overexpressed membrane
protein is essential.
As shown before for human and rat renal AQP2 and hu-
man AQP2 heterologously expressed in Xenopus oocytes [32],
sucrose gradient sedimentation analysis and subsequent im-
munoblotting revealed that HT-AQP2 existed as a homotet-
ramer (Fig. 3), indicating that the poly-histidine tag did not
disturb the formation of the normal quaternary structure of
AQP2. This was con¢rmed by electron microscopy of nega-
tively stained HT-AQP2 preparations. Finally, stopped-£ow
light scattering of puri¢ed reconstituted HT-AQP2 (Fig. 5)
yielded a single channel water permeability coe⁄cient of
0.93 þ 0.03U10313 cm3/s, which is in between that of AQP4
(1.5U10313 cm3/s; [43]) and that of AQP1 (0.5U10313 cm3/s;
[33]). These results indicate that in HT-AQP2 the poly-histi-
dine tag does neither impair correct folding and tetrameriza-
tion of the protein, nor the function of the water pore.
In conclusion, we have been able to isolate high amounts of
structurally and functionally intact human AQP2, which is
now available for crystallization and structural analyses. The
structure of HT-AQP2 will provide clues to understanding
functionality and regulation of AQP2, and will pave the
road for rational design of AQP2 blockers that might ulti-
mately be useful as AQP2-speci¢c diuretics in patients su¡er-
ing from congestive heart failure, liver cirrhosis and pre-
eclampsia.
Acknowledgements: We wish to thank Dr. Gu«nter Pappenberger and
Dr. Ignacio E. Sanchez for their help with the stopped-£ow measure-
ments, and Kitaru Suda for LPR determinations. This work was
supported by the EU Grant BFO4-CT98-0024 to P.M.T.D. and
A.E., and EU Grant BMH4-97-2327 to W.J.D.G. P.M.T.D. is an
investigator of the Royal Netherlands Academy of Arts and Sciences.
References
[1] Heymann, J.B. and Engel, A. (2000) J. Mol. Biol. 295, 1039^
1053.
[2] King, L.S., Yasui, M. and Agre, P. (2000) Mol. Med. Today 6,
60^65.
[3] Deen, P.M.T. and van Os, C.H. (1998) Curr. Opin. Cell Biol. 10,
435^442.
[4] Agre, P. (2000) J. Am. Soc. Nephrol. 11, 764^777.
[5] van Os, C.H. and Deen, P.M.T. (1998) Nephrol. Dial. Trans-
plant. 13, 1645^1651.
[6] Deen, P.M.T. and Knoers, N.V.A.M. (1998) Curr. Opin. Neph-
rol. Hypertens. 7, 37^42.
[7] Knepper, M.A., Verbalis, J.G. and Nielsen, S. (1997) Curr. Opin.
Nephrol. Hypertens. 6, 367^371.
[8] Nielsen, S., Frokiaer, J. and Knepper, M.A. (1998) Curr. Opin.
Nephrol. Hypertens. 7, 509^516.
[9] Mulders, S.M., Bichet, D.G., Rijss, J.P., Kamsteeg, E.J., Arthus,
M.F., Lonergan, M., Fujiwara, M., Morgan, K., Leijendekker,
R., van der, S.P., van Os, C.H. and Deen, P.M.T. (1998) J. Clin.
Invest. 102, 57^66.
[10] Deen, P.M.T., Verdijk, M.A.J., Knoers, N.V.A.M., Wieringa, B.,
Monnens, L.A.H., van Os, C.H. and van Oost, B.A. (1994) Sci-
ence 264, 92^95.
[11] Nielsen, S., Kwon, T.H., Christensen, B.M., Promeneur, D., Fro-
kiaer, J. and Marples, D. (1999) J. Am. Soc. Nephrol. 10, 647^
663.
[12] Xu, L., Poole, D.C. and Musch, T.I. (1998) Med. Sci. Sports
Exerc. 30, 1230^1237.
[13] Nielsen, S., Terris, J., Andersen, D., Ecelbarger, C., Frokiaer, J.,
Jonassen, T., Marples, D., Knepper, M.A. and Petersen, J.S.
(1997) Proc. Natl. Acad. Sci. USA 94, 5450^5455.
[14] Schrier, R.W., Fassett, R.G., Ohara, M. and Martin, P.Y. (1998)
Proc. Assoc. Am. Physicians 110, 407^411.
[15] Jonassen, T.E., Nielsen, S., Christensen, S. and Petersen, J.S.
(1998) Am. J. Physiol. 275, F216^F225.
[16] Asahina, Y., Izumi, N., Enomoto, N., Sasaki, S., Fushimi, K.,
Marumo, F. and Sato, C. (1995) Hepatology 21, 169^173.
[17] Fernandez-Llama, P., Turner, R., Dibona, G. and Knepper,
M.A. (1999) J. Am. Soc. Nephrol. 10, 1950^1957.
[18] Pearson, J.F. (1992) Br. J. Hosp. Med. 48, 47^51.
[19] Schrier, R.W., Ohara, M., Rogachev, B., Xu, L. and Knotek, M.
(1998) Mol. Genet. Metab. 65, 255^263.
[20] Sui, H., Walian, P.J., Tang, G., Oh, A. and Jap, B.K. (2000)
Acta Crystallogr. D. Biol. Crystallogr. 56, 1198^1200.
[21] Ringler, P., Borgnia, M.J., Stahlberg, H., Maloney, P.C., Agre,
P. and Engel, A. (1999) J. Mol. Biol. 291, 1181^1190.
[22] Braun, T., Phillippsen, A., Wirtz, S., Borgnia, M.J., Agre, P.,
Ku«hlbrandt, W., Engel, A. and Stahlberg, H. (2000) EMBO
Rep. 1, 183^189.
[23] Lampe, P.D. and Johnson, R.G. (1990) Eur. J. Biochem. 194,
541^547.
[24] Walz, T., Hirai, T., Murata, K., Heymann, J.B., Mitsuoka, K.,
Fujiyoshi, Y., Smith, B.L., Agre, P. and Engel, A. (1997) Nature
387, 624^627.
[25] Fushimi, K., Uchida, S., Hara, Y., Hirata, Y., Marumo, F. and
Sasaki, S. (1993) Nature 361, 549^552.
[26] Brown, D., Katsura, T., Kawashima, M., Verkman, A.S. and
Sabolic, I. (1995) Histochem. Cell Biol. 104, 1^9.
[27] Parks, T.D., Leuther, K.K., Howard, E.D., Johnston, S.A. and
Dougherty, W.G. (1994) Anal. Biochem. 216, 413^417.
[28] Klaassen, C.H.W., Bovee-Geurts, P.H.M., de Caluwe, G.L. and
de Grip, W.J. (1999) Biochem. J. 342, 293^300.
[29] Deen, P.M.T., Rijss, J.P., Mulders, S.M., Errington, R.J., van
Baal, J. and van Os, C.H. (1997) J. Am. Soc. Nephrol. 8, 1493^
1501.
[30] Deen, P.M.T., Croes, H., van Aubel, R.A., Ginsel, L.A. and van
Os, C.H. (1995) J. Clin. Invest. 95, 2291^2296.
[31] Kistler, J., Goldie, K., Donaldson, P. and Engel, A. (1994) J. Cell
Biol. 126, 1047^1058.
[32] Kamsteeg, E.J., Wormhoudt, T.A., Rijss, J.P., van Os, C.H. and
Deen, P.M.T. (1999) EMBO J. 18, 2394^2400.
[33] Walz, T., Smith, B.L., Zeidel, M.L., Engel, A. and Agre, P.
(1994) J. Biol. Chem. 269, 1583^1586.
[34] van Heeswijk, M.P. and van Os, C.H. (1986) J. Membr. Biol. 92,
183^193.
[35] Kaplan, R.S. and Pedersen, P.L. (1985) Anal. Biochem. 150, 97^
104.
[36] Stewart, J.C. (1980) Anal. Biochem. 104, 10^14.
[37] Walz, T., Smith, B.L., Agre, P. and Engel, A. (1994) EMBO J.
13, 2985^2993.
FEBS 25112 24-8-01
P.J.L. Werten et al./FEBS Letters 504 (2001) 200^205204
[38] Daniels, M.J., Chrispeels, M.J. and Yeager, M. (1999) J. Mol.
Biol. 294, 1337^1349.
[39] Hasler, L., Walz, T., Tittmann, P., Gross, H., Kistler, J. and
Engel, A. (1998) J. Mol. Biol. 279, 855^864.
[40] Smith, B.L. and Agre, P. (1991) J. Biol. Chem. 266, 6407^6415.
[41] Saxton, W.O., Pitt, J.T. and Horner, M. (1979) Ultramicroscopy
4, 343^354.
[42] Schulein, R., Rutz, C. and Rosenthal, W. (1997) Protein Eng. 10,
707^713.
[43] Yang, B., van Hoek, A.N. and Verkman, A.S. (1997) Biochem-
istry 36, 7625^7632.
FEBS 25112 24-8-01
P.J.L. Werten et al./FEBS Letters 504 (2001) 200^205 205
